Transcriptomic profiling data provided by The Cancer Genome Atlas (TCGA) [13] show that MAPK4 expression is correlated with the survival rates in patients with lung cancer, bladder cancer and glioma. The gene discussed is MAPK4; the disease is central nervous system cancer.